Development and delivery of anti-tuberculosis drugs, vaccines and immunotherapeutics

Editorial

James A Triccas et al. Adv Drug Deliv Rev. 2016.

. 2016 Jul 1:102:1-2.

doi: 10.1016/j.addr.2016.05.017.

No abstract available

Comment on

Challenges in the clinical assessment of novel tuberculosis drugs.
Dooley KE, Phillips PP, Nahid P, Hoelscher M. Dooley KE, et al. Adv Drug Deliv Rev. 2016 Jul 1;102:116-22. doi: 10.1016/j.addr.2016.01.014. Epub 2016 Jan 28. Adv Drug Deliv Rev. 2016. PMID: 26827911 Free PMC article. Review.
Dry powder inhalable formulations for anti-tubercular therapy.
Parumasivam T, Chang RY, Abdelghany S, Ye TT, Britton WJ, Chan HK. Parumasivam T, et al. Adv Drug Deliv Rev. 2016 Jul 1;102:83-101. doi: 10.1016/j.addr.2016.05.011. Epub 2016 May 17. Adv Drug Deliv Rev. 2016. PMID: 27212477 Review.

[Treatment of fibro-cavernous tuberculosis by means of a prolonged administration of tuberculostatic drugs].
DOSEN D. DOSEN D. Tuberkuloza. 1959 Oct-Dec;11:516-24. Tuberkuloza. 1959. PMID: 13817739 Undetermined Language. No abstract available.
Availability of anti-tuberculosis drugs in Europe.
Sotgiu G, D'Ambrosio L, Centis R, Bothamley G, Cirillo DM, De Lorenzo S, Guenther G, Kliiman K, Muetterlein R, Spinu V, Villar M, Zellweger JP, Sandgren A, Huitric E, Lange C, Manissero D, Migliori GB. Sotgiu G, et al. Eur Respir J. 2012 Aug;40(2):500-3. doi: 10.1183/09031936.00009212. Eur Respir J. 2012. PMID: 22855471 No abstract available.
[RESEARCH ON URINARY EXCRETION OF 5-HYDROXY-INDOLACETIC ACID IN PATIENTS WITH PULMONARY TUBERCULOSIS. ITS RELATION TO THE ADMINISTRATION OF ANTIBACILLARY DRUGS].
REY JC, VACCAREZZA JR, RUIZ DC. REY JC, et al. Prensa Med Argent. 1965 Jun 4;52:1251-3. Prensa Med Argent. 1965. PMID: 14333826 Spanish. No abstract available.
[Development of antituberculous drugs: current status and future prospects].
Tomioka H, Namba K. Tomioka H, et al. Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
[ON THE EPIDEMIOLOGY OF TUBERCULOSIS IN CHILDREN AND THE NECESSITY OF POTENTIATING VACCINAL ANTITUBERCULAR PROPHYLAXIS].
BARBERI S, DELUCA R. BARBERI S, et al. Clin Pediatr (Bologna). 1964 Feb;46:95-109. Clin Pediatr (Bologna). 1964. PMID: 14200714 Review. Italian. No abstract available.